Sites and Contacts
Our site in Vizag, India develops and manufactures small molecule APIs, new chemical entities (NCEs) and intermediates from kilograms to tons, supporting all phases of your drug’s lifecycle.
Home to more than 200 employees, the site comprises a combination of GMP and technical work areas, 140 cubic meters of vessel capacity manufacturing more than 500 tons of small molecule APIs.
This site features specialized technologies: a fully automated state-of-the-art production plant for mesalazine, electrochemical reactions, hydrogenations and cryogenic reactions.
- One cGMP pilot plant
- Two commercial scale production units
- Four production trains
- Custom development and analytical laboratories
- cGMP kilo laboratory
- Strong regulatory history – most recent inspections:
- CDSCO (IN), regularly, 2018
- FDA (US), regularly, 2018
- PMDA (JP), 2018
- Government of Upper Bavaria, competent authority (Germany), regularly, 2017
- KFDA (Korea), 2011
Other important facts
We take in pride in our long, regulatory track record; with the most recent site inspection in December 2018 by the US FDA resulted in ‘No Action Indicated’ outcome.
Please click here to find out about Vizag’s specific Corporate Social Responsibility Policy.
PharmaZell (India) Private Limited
Plot No. 115, Ramky Pharma city (India) Ltd. SEZ
Parawada Visakhapatnam – 531019 Andhra Pradesh
Tel: +91 8924 236015
Fax: +91 8924 236016